Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 30 studies | 35% ± 13% | |
classical monocyte | 24 studies | 36% ± 12% | |
conventional dendritic cell | 24 studies | 43% ± 15% | |
non-classical monocyte | 23 studies | 50% ± 14% | |
dendritic cell | 17 studies | 42% ± 21% | |
monocyte | 16 studies | 34% ± 13% | |
B cell | 11 studies | 25% ± 8% | |
naive B cell | 11 studies | 22% ± 6% | |
myeloid cell | 11 studies | 38% ± 12% | |
endothelial cell | 8 studies | 26% ± 8% | |
alveolar macrophage | 7 studies | 37% ± 11% | |
goblet cell | 7 studies | 30% ± 6% | |
microglial cell | 7 studies | 32% ± 13% | |
precursor B cell | 6 studies | 33% ± 9% | |
endothelial cell of lymphatic vessel | 6 studies | 29% ± 6% | |
mononuclear phagocyte | 5 studies | 34% ± 14% | |
hematopoietic stem cell | 5 studies | 30% ± 9% | |
pro-B cell | 5 studies | 36% ± 6% | |
epithelial cell | 5 studies | 33% ± 2% | |
hematopoietic precursor cell | 4 studies | 42% ± 15% | |
memory B cell | 4 studies | 18% ± 2% | |
natural killer cell | 4 studies | 21% ± 4% | |
immature B cell | 4 studies | 25% ± 5% | |
brush cell | 4 studies | 24% ± 5% | |
plasmacytoid dendritic cell | 4 studies | 29% ± 9% | |
endothelial cell of vascular tree | 3 studies | 16% ± 0% | |
tissue-resident macrophage | 3 studies | 28% ± 11% | |
intermediate monocyte | 3 studies | 50% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 4114.33 | 578 / 578 | 95% | 42.04 | 1099 / 1155 |
stomach | 97% | 4389.47 | 348 / 359 | 97% | 64.69 | 278 / 286 |
breast | 99% | 1796.15 | 453 / 459 | 94% | 32.02 | 1049 / 1118 |
intestine | 93% | 4978.05 | 901 / 966 | 99% | 63.13 | 522 / 527 |
esophagus | 90% | 1079.10 | 1307 / 1445 | 97% | 39.96 | 177 / 183 |
bladder | 90% | 1357.14 | 19 / 21 | 90% | 49.34 | 455 / 504 |
ovary | 74% | 747.31 | 134 / 180 | 96% | 45.91 | 412 / 430 |
uterus | 79% | 885.50 | 135 / 170 | 91% | 39.35 | 416 / 459 |
thymus | 89% | 953.19 | 583 / 653 | 73% | 19.20 | 443 / 605 |
pancreas | 65% | 759.25 | 212 / 328 | 95% | 64.93 | 169 / 178 |
kidney | 73% | 1020.13 | 65 / 89 | 83% | 22.23 | 744 / 901 |
brain | 49% | 528.99 | 1284 / 2642 | 85% | 25.02 | 598 / 705 |
adrenal gland | 97% | 1345.13 | 249 / 258 | 34% | 5.42 | 78 / 230 |
skin | 53% | 455.85 | 954 / 1809 | 77% | 26.42 | 365 / 472 |
prostate | 91% | 1156.84 | 223 / 245 | 39% | 5.22 | 195 / 502 |
lymph node | 0% | 0 | 0 / 0 | 100% | 129.16 | 29 / 29 |
peripheral blood | 100% | 7880.64 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 9592.34 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 2421.25 | 1196 / 1204 | 0% | 0 | 0 / 0 |
liver | 37% | 380.09 | 84 / 226 | 58% | 17.10 | 237 / 406 |
tonsil | 0% | 0 | 0 / 0 | 93% | 57.14 | 42 / 45 |
heart | 85% | 867.12 | 734 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 66% | 893.96 | 884 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 36% | 6.83 | 29 / 80 |
muscle | 9% | 62.30 | 76 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2001190 | Biological process | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
GO_0043305 | Biological process | negative regulation of mast cell degranulation |
GO_0071636 | Biological process | positive regulation of transforming growth factor beta production |
GO_0070241 | Biological process | positive regulation of activated T cell autonomous cell death |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0006954 | Biological process | inflammatory response |
GO_0032753 | Biological process | positive regulation of interleukin-4 production |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0032834 | Biological process | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response |
GO_0032673 | Biological process | regulation of interleukin-4 production |
GO_0032736 | Biological process | positive regulation of interleukin-13 production |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0032735 | Biological process | positive regulation of interleukin-12 production |
GO_0002519 | Biological process | natural killer cell tolerance induction |
GO_2000670 | Biological process | positive regulation of dendritic cell apoptotic process |
GO_0097029 | Biological process | mature conventional dendritic cell differentiation |
GO_0046598 | Biological process | positive regulation of viral entry into host cell |
GO_0006935 | Biological process | chemotaxis |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0070555 | Biological process | response to interleukin-1 |
GO_0007565 | Biological process | female pregnancy |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0098586 | Biological process | cellular response to virus |
GO_2000510 | Biological process | positive regulation of dendritic cell chemotaxis |
GO_0045953 | Biological process | negative regulation of natural killer cell mediated cytotoxicity |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0046007 | Biological process | negative regulation of activated T cell proliferation |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_2000563 | Biological process | positive regulation of CD4-positive, alpha-beta T cell proliferation |
GO_2001269 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0034142 | Biological process | toll-like receptor 4 signaling pathway |
GO_1900744 | Biological process | regulation of p38MAPK cascade |
GO_2001200 | Biological process | positive regulation of dendritic cell differentiation |
GO_0071639 | Biological process | positive regulation of monocyte chemotactic protein-1 production |
GO_0032682 | Biological process | negative regulation of chemokine production |
GO_0032689 | Biological process | negative regulation of type II interferon production |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_2000562 | Biological process | negative regulation of CD4-positive, alpha-beta T cell proliferation |
GO_0034134 | Biological process | toll-like receptor 2 signaling pathway |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0038066 | Biological process | p38MAPK cascade |
GO_0032674 | Biological process | regulation of interleukin-5 production |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0060135 | Biological process | maternal process involved in female pregnancy |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0005615 | Cellular component | extracellular space |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0016936 | Molecular function | galactoside binding |
GO_0048030 | Molecular function | disaccharide binding |
GO_0005534 | Molecular function | galactose binding |
Gene name | LGALS9 |
Protein name | Galectin 9 Galectin-9 (Gal-9) (Ecalectin) (Tumor antigen HOM-HD-21) Galectin |
Synonyms | |
Description | FUNCTION: Binds galactosides . Has high affinity for the Forssman pentasaccharide . Ligand for HAVCR2/TIM3 . Binding to HAVCR2 induces T-helper type 1 lymphocyte (Th1) death . Also stimulates bactericidal activity in infected macrophages by causing macrophage activation and IL1B secretion which restricts intracellular bacterial growth (By similarity). Ligand for P4HB; the interaction retains P4HB at the cell surface of Th2 T-helper cells, increasing disulfide reductase activity at the plasma membrane, altering the plasma membrane redox state and enhancing cell migration . Ligand for CD44; the interaction enhances binding of SMAD3 to the FOXP3 promoter, leading to up-regulation of FOXP3 expression and increased induced regulatory T (iTreg) cell stability and suppressive function (By similarity). Promotes ability of mesenchymal stromal cells to suppress T-cell proliferation . Expands regulatory T-cells and induces cytotoxic T-cell apoptosis following virus infection . Activates ERK1/2 phosphorylation inducing cytokine (IL-6, IL-8, IL-12) and chemokine (CCL2) production in mast and dendritic cells . Inhibits degranulation and induces apoptosis of mast cells . Induces maturation and migration of dendritic cells . Inhibits natural killer (NK) cell function . Can transform NK cell phenotype from peripheral to decidual during pregnancy . Astrocyte derived galectin-9 enhances microglial TNF production (By similarity). May play a role in thymocyte-epithelial interactions relevant to the biology of the thymus. May provide the molecular basis for urate flux across cell membranes, allowing urate that is formed during purine metabolism to efflux from cells and serving as an electrogenic transporter that plays an important role in renal and gastrointestinal urate excretion (By similarity). Highly selective to the anion urate (By similarity). .; FUNCTION: [Isoform 2]: Acts as an eosinophil chemoattractant . It also inhibits angiogenesis . Suppresses IFNG production by natural killer cells (By similarity). . |
Accessions | ENST00000302228.9 [O00182-2] J3QKK6 ENST00000580779.5 ENST00000577392.5 J3QS92 ENST00000578944.1 J3KS82 ENST00000395473.7 [O00182-1] J3KSA0 ENST00000467111.5 O00182 ENST00000581710.5 ENST00000313648.10 [O00182-4] K7EPS0 ENST00000584661.5 |